Gene Therapy Safety

Risks & contraindications

Evidence quality

Highlighted claims

• More than 6,000 patients had received AAV-based gene therapy without serious harm reported in the article context. — A rare case of gene therapy-linked cancer
• The case suggests that comparatively low-risk gene therapy platforms can still carry residual risks. — A rare case of gene therapy-linked cancer
• The event has safety implications for patients who receive gene therapy. — A rare case of gene therapy-linked cancer
• The rare case does not change the basic preference for AAV vectors in gene therapy. — A rare case of gene therapy-linked cancer